Loading...
Docoh

Monopar Therapeutics (MNPR)

Employees
Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 28, 2022, Monopar Therapeutics, Inc. (the “Company”) held its Annual Meeting. A total of 12,621,591.614 shares of the Company’s common stock were entitled to vote as of May 2, 2022, the record date for the Annual Meeting, of which 10,091,324.602 shares were represented in person or by proxy at the Annual Meeting. At the Annual Meeting, the stockholders of the Company voted on the following proposals:

(1) the election of five directors, to serve as directors until the Company’s next annual meeting of stockholders or until their respective successors are duly elected and qualified;

(2) the ratification of the selection of BPM LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2022; and

(3) to approve an amendment to the 2016 Stock Incentive Plan to increase the authorized shares of common stock available for awards thereunder.

Proposal 1 – Election of Directors

At the Annual Meeting, the voting results with respect to the proposal for the election of directors, included in the Company’s Proxy Statement on Schedule 14A for the Annual Meeting, were as follows:

DirectorForWithheldBroker Non-Votes
Christopher M. Starr, Ph.D.9,053,461.20224,571.5001,013,291.900
Chandler D. Robinson, MD MBA MSc9,053,411.50224,621.2001,013,291.900
Michael J. Brown, MSc8,927,306.202150,726.5001,013,291.900
Raymond W. Anderson, MBA8,939,612.202138,420.5001,013,291.900
Arthur J. Klausner, MBA8,790,428.202287,604.5001,013,291.900

Accordingly, each of the foregoing persons was elected as a director at the Annual Meeting.

Proposal 2 – Ratification of Selection of Independent Registered Public Accounting Firm

The voting results with respect to the proposal to ratify the selection of BPM LLP to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2022, were as follows:

ForAgainstAbstainBroker Non-Votes
10,068,930.80216,011.1006,382.700N/A

Accordingly, the Company’s stockholders ratified the selection of BPM LLP to serve as the Company’s independent registered public accounting firm for the year ending December 31, 2022.

Proposal 3 – Approve an Amendment to the 2016 Stock Incentive Plan

The voting results with respect to the approval an amendment to the 2016 Stock Incentive Plan to increase the authorized shares of common stock available for awards thereunder are as follows:

ForAgainstAbstainBroker Non-Votes
8,701,878.230365,873.47210,2811,013,291.900

Accordingly, the Company’s stockholders approved the amendment to the 2016 Stock Incentive Plan to increase the authorized shares of common stock available for awards.

No other matters were submitted to a vote of stockholders at the Annual Meeting.

2